SCHEMBL18924665

SCHEMBL18924665

CCc1cc(-c2ccncc2)cs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
MAPT P10636 3/20 0.44
ALDH1A1 P00352 8/20 0.44
APOBEC3G Q9HC16 2/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
HPGD P15428 6/20 0.40
GAA P10253 3/20 0.40
DAO P14920 1/20 0.40
TMIGD3 P0DMS9 1/20 0.40
ADORA1 P30542 1/20 0.40
ALOX12 P18054 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GFER P55789 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
HTT P42858 1/20 0.39
NOTUM Q6P988 1/20 0.38
KLKB1 P03952 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL842665 0.82 CYP3A4 (0.46) LMNAMAPTALDH1A1APOBEC3GCYP11B1
SCHEMBL12531530 0.82 CYP11B1 (0.49) LMNAMAPTALDH1A1APOBEC3GCYP11B1
SCHEMBL12531203 0.80 DYRK1A (0.62) ALDH1A1CYP11B1CYP11B2CYP3A4CYP2D6
SCHEMBL27500112 0.79 ALDH1A1 (0.38) LMNAALDH1A1APOBEC3GCYP11B1CYP11B2
SCHEMBL12531324 0.78 ALAD (0.47) LMNAMAPTALDH1A1APOBEC3GHPGD
SCHEMBL17503909 0.75 KLK1 (0.50) LMNAMAPTALDH1A1APOBEC3GCYP11B1
SCHEMBL10160789 0.73 CYP1A2 (0.44) LMNAMAPTALDH1A1APOBEC3GHPGD
SCHEMBL5226951 0.72 MAPT (0.50) LMNAMAPTALDH1A1APOBEC3GHPGD
Propane SCHEMBL28169987 0.72 MAPT (0.73) LMNAMAPTALDH1A1APOBEC3GHPGD
SCHEMBL28318687 0.70 DYRK1A (0.59) LMNAMAPTKDM4ECYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834513-B2 Benzylamine derivatives Kalvista Pharmceuticals Limited (GB) 2017-12-05 US disclosed
US-20170253561-A1 Benzylamine Derivatives KALVISTA PHARMACEUTICALS LTD (GB) 2017-09-07 US disclosed
US-9670157-B2 Benzylamine derivatives KALVISTA PHARMACEUTICALS LIMITED (GB) 2017-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170253561-A1 Benzylamine Derivatives BDKRB1, BDKRB2, KLKB1 LMNA 619/4885MAPT 3370/4885ALDH1A1 2364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.